ADA Scientific Sessions 2025 Abstract
PG-110, a Novel Bispecific Antibody Targeting ActRII and Myostatin, Enhances Fat-Specific Weight Loss and Improves Bone Health in Combination with GLP-1 Agonist Therapy
Experiments in miceGLP-1 receptor agonists
66 papers6 new in 30 days